Given that the inflammatory tumor microenvironment contains free oxygen radicals from oxidative stress and pro-inflammatory cytokines, follow-up studies have suggested that these factors might be the main drivers of the inflammation-driven loss of nuclear MSH3. Here, MSH3 is linked to neoplasm.